OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Maria-Chiara Marinozzi, Sophie Chauvet, Moglie Le Quintrec, et al.
Kidney International (2017) Vol. 92, Iss. 5, pp. 1232-1241
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

C3 glomerulopathy — understanding a rare complement-driven renal disease
Richard J. Smith, Gerald B. Appel, Anna M. Blom, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 3, pp. 129-143
Open Access | Times Cited: 293

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice
Nine V.A.M. Knoers, Corinne Antignac, Carsten Bergmann, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 2, pp. 239-254
Open Access | Times Cited: 114

The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Marina Vivarelli, Jonathan Barratt, Laurence H. Beck, et al.
Kidney International (2024) Vol. 106, Iss. 3, pp. 369-391
Open Access | Times Cited: 30

Complement and systemic lupus erythematosus
Chau‐Ching Liu, Susan Manzi, Joseph M. Ahearn
Elsevier eBooks (2024), pp. 245-264
Closed Access | Times Cited: 20

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
Moglie Le Quintrec, Anne‐Laure Lapeyraque, Arnaud Lionet, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 1, pp. 84-92
Closed Access | Times Cited: 120

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN
Paraskevas Iatropoulos, Erica Daina, Manuela Curreri, et al.
Journal of the American Society of Nephrology (2017) Vol. 29, Iss. 1, pp. 283-294
Open Access | Times Cited: 113

Interpretation of Serological Complement Biomarkers in Disease
Kristina Nilsson Ekdahl, Barbro Persson, Camilla Mohlin, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 96

C3‐dependent effector functions of complement
Alessandra Zarantonello, Margot Revel, Anne Grünenwald, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 120-138
Open Access | Times Cited: 59

Developments in anti-complement therapy; from disease to clinical trial
Claire L. Harris, Richard B. Pouw, David Kavanagh, et al.
Molecular Immunology (2018) Vol. 102, pp. 89-119
Open Access | Times Cited: 81

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
Sophie Chauvet, Lubka T. Roumenina, Pièrre Aucouturier, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 69

Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations
Fernando Corvillo, Marcin Okrój, Pilar Nozal, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 68

The role of the alternative pathway of complement activation in glomerular diseases
Emilia Łukawska, Magdalena Polcyn-Adamczak, Zofia I Niemir
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 3, pp. 297-318
Open Access | Times Cited: 67

C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial
Piero Ruggenenti, Erica Daina, Alessia Gennarini, et al.
American Journal of Kidney Diseases (2019) Vol. 74, Iss. 2, pp. 224-238
Closed Access | Times Cited: 60

Anti-Factor B Antibodies and Acute Postinfectious GN in Children
Sophie Chauvet, Romain Berthaud, Magali Devriese, et al.
Journal of the American Society of Nephrology (2020) Vol. 31, Iss. 4, pp. 829-840
Open Access | Times Cited: 60

Update on C3 Glomerulopathy: A Complement-Mediated Disease
Fernando Caravaca‐Fontán, Laura Lucientes, Teresa Cavero, et al.
˜The œNephron journals/Nephron journals (2020) Vol. 144, Iss. 6, pp. 272-280
Open Access | Times Cited: 57

The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease
Federica Defendi, Nicole M. Thielens, Giovanna Clavarino, et al.
Clinical Reviews in Allergy & Immunology (2019) Vol. 58, Iss. 2, pp. 229-251
Open Access | Times Cited: 56

Complement-mediated kidney diseases
Felix Poppelaars, Joshua M. Thurman
Molecular Immunology (2020) Vol. 128, pp. 175-187
Open Access | Times Cited: 50

C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease
Amanda K. Heiderscheit, Jill J. Hauer, Richard J. Smith
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 3, pp. 344-357
Open Access | Times Cited: 30

Recurrent C3 glomerulopathy after kidney transplantation
Shota Obata, Pedro A S Vaz de Castro, Leonardo V. Riella, et al.
Transplantation Reviews (2024) Vol. 38, Iss. 2, pp. 100839-100839
Closed Access | Times Cited: 7

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System
Dennis Pedersen, Trine A.F. Gadeberg, Caroline Thomas, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN
Roberta Donadelli, Patrizia Pulieri, Rossella Piras, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 48

Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
Fádi Fakhouri, Moglie Le Quintrec, Véronique Frémeaux‐Bacchi
Kidney International (2020) Vol. 98, Iss. 5, pp. 1135-1148
Open Access | Times Cited: 44

Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Hannah J. Lomax-Browne, Nicholas Medjeral‐Thomas, Sean J. Barbour, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 7, pp. 994-1007
Open Access | Times Cited: 26

Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
Sophie Chauvet, Jill J. Hauer, Florent Petitprez, et al.
Kidney International (2022) Vol. 102, Iss. 4, pp. 904-916
Open Access | Times Cited: 24

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy
Marina Noris, Roberta Donadelli, Giuseppe Remuzzi
Pediatric Nephrology (2018) Vol. 34, Iss. 8, pp. 1311-1323
Closed Access | Times Cited: 43

Page 1 - Next Page

Scroll to top